Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 4, 2008, Pages 499-505

  Skalicky, Jiri ^a   Muzakova, Vladimira ^b   Kandar, Roman ^b   Meloun, Milan ^b   Rousar, Tomas ^b   Palicka, Vladimir ^c  

^a Pardubice Regional Hospital   (Czech Republic)

^b UNIVERSITY OF PARDUBICE   (Czech Republic)

^c UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Inflammation; Metabolic syndrome; Oxidative stress

Indexed keywords

ALLANTOIN; ALPHA 1 ANTITRYPSIN; ALPHA TOCOPHEROL; C REACTIVE PROTEIN; FIBRINOGEN; FREE RADICAL; GLUTATHIONE DISULFIDE; MALONALDEHYDE;

ABDOMINAL FAT; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BLOOD CHEMICAL ANALYSIS; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OXIDATIVE STRESS;

EID: 44949249095     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.096     Document Type: Article

References (40)

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486-97.
2. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutritional Examination Survey II Mortality Study. Atherosclerosis 2004;173:309-14.
3. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.
4. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle aged men. J Am Med Assoc 2002;288:2709-16.
5. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-50.
6. Butler J, Rodondi N, Zhu Y, Figaro K, Fazio S, Vaughan DE, et al. Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol 2006;47:1595-602.
7. Maggi S, Noale M, Gallina P, Bianchi D, Marzari Ch, Limongi F, et al. Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging. J Gerontol A Biol Sci Med Sci 2006;61:505-10.
8. Votruba M, Stopka P, Hroudová J, Veselý K, Nejedlová L. A simple method for quantitative estimation of free radicals in serum. Klin Biochem Metab 1999;7:96-101.
9. Kumar SS, Devasagayam TP, Bhushan B, Verma NC. Scavenging of reactive oxygen species by chlorophyllin: an ESR study. Free Radical Res 2001;35:563-74.
10. Kučera O, Červinková Z, Lotková H, Křiváková P, Roušar T, Mužáková V, et al. Protective effect of S-adenosylmethionine against D-galactosamine-induced injury of rat hepatocytes in primary culture. Physiol Res 2006;55:551-60.
11. Mužáková V, Vojtíšek P, Meloun M, Vaňková R, Roušar T, Červinková Z. Antioxidant vitamin levels do not exhibit negative correlation with the extent of acute myocardial infarction. Physiol Res 2005;54:623-9.
12. Kand'ár R, Žáková P, Mužá ková V. Monitoring of antioxidant properties of uric acid in humans for a consideration measuring of levels of allantoin in plasma by liquid chromatography. Clin Chim Acta 2006;365:249-56.
13. Hiramatsu K, Arimori S. Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes 1988;37:832-7.
14. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beamont FJ, et al. Oxidative stress in arterial hypertension: role of NAD(p)H oxidase. Hypertension 2001;38:1395-9.
15. Brasier AR, Resinos A III, Eledrisi MS. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 2002;22:1257-66.
16. Knopp RH, Paramsothy P. Oxidized LDL and abdominal obesity: a key to understanding the metabolic syndrome. Am J Clin Nutr 2006;83:1-2.
17. Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman J, et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004;89:4963-71.
18. Mezzetti A, Cipollone F, Cuccurullo F. Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm. Cardiovasc Res 2000;47:475-88.
19. Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, et al. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1997;27:484-90.
20. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 1993;90:6434-8.
21. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000;49:1939-45.
22. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations. Diabetes 2003;52:2346-52.
23. Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Caan B, et al. Factors associated with oxidative stress in human population. Am J Epidemiol 2002;156:274-85.
24. 2-isoprostanes in plasma of smokers. Cancer Epidemiol Biomarkers Prev 2002;11:7-13.
25. Trevisan M, Browne R, Ram M, Muti P, Freudenhaim J, Carosella AM, et al. Correlates of markers of oxidative status in the general population. Am J Epidemiol 2001;154:348-56.
26. Weinbrenner T, Schroder H, Escurriol V, Fito M, Elosua R, Vila J, et al. Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr 2006;83:30-5.
27. Barinas-Mitchell E, Cushman M, Meilahn EN, Tracy RP, Kuller LH. Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women. Am J Epidemiol 2001;153:1094-101.
28. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 2000;23:835-9.
29. Das UN. Obesity, metabolic syndrome X, and inflammation. Nutrition 2002;18:430-2.
30. Van Guilder GP, Hoetzer GL, Greiner JL, Stauffer BL, DeSouza ChA. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity 2006;14:2127-31.
31. Roebuck KA. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB. Int J Mol Med 1999;4:223-30.
32. Lane N. A unifying view of ageing and disease: the double-agent theory. J Theor Biol 2003;225:531-40.
33. Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 1999;277:E971-5.
34. Ridker PM, Rifai N, Stampfer MJ, Hennekens ChH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767-72.
35. Davi G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, et al. Platelet activation in obese women: role of inflammation and oxidant stress. J Am Med Assoc 2002;288:2008-14.
36. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-61.
37. Sonnenberg GE, Krakower GR, Kissebah AH. A novel pathway to the manifestations of metabolic syndrome. Obes Res 2004;12:180-6.
38. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004;24:816-23.
39. Keaney JF, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, et al. Obesity and systemic oxidative stress. Clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003;23:434-9.
40. Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, et al. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the Health, Aging, and Body Composition Cohort. Diabetes 2004;53:1068-73.